Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,018 across all filing types
Latest filing 2020-01-13 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20200113 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA alienated (sold/issued) its own shares following option exercises by personnel, specifically mentioning these actions are in the context of variable long-term remuneration. The date is January 13, 2020, and it is classified as "information réglementée" (regulated information). This activity—the company buying back or issuing its own shares, often related to employee stock plans—directly corresponds to the definition of 'Transaction in Own Shares'.
2020-01-13 French
20100113 - Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB NV delivered its own shares to employees as part of long-term incentive plans (stock options). This activity directly relates to the company managing its own share capital through repurchase or issuance/delivery. The most specific category for this is 'Transaction in Own Shares' (POS). It is not a general financing announcement (CAP), nor is it a director's dealing (DIRS), as these are employee incentive plan exercises, not personal trades by directors. The document is a formal announcement ('gereglementeerde informatie') detailing specific transactions.
2020-01-13 Dutch
200113-Transparency notification press release Blackrock .pdf
Major Shareholding Notification Classification · 99% confidence The document is a 'Transparency notification' from BlackRock, Inc. to UCB SA/NV, explicitly stating that a shareholding threshold (5%) was crossed on a specific date (7 January 2020). It details the number of voting rights and equivalent financial instruments held by various affiliates of BlackRock. This type of filing, concerning changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a general regulatory announcement (RNS), but a specific disclosure required when ownership crosses statutory thresholds.
2020-01-13 English
200113- Notification de transparence comm.de presse Blackrock.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Déclaration de transparence' (Transparency Declaration) issued by UCB SA announcing that BlackRock, Inc. crossed the 5% threshold of voting shares on January 7, 2020. This type of filing, which reports changes in significant share ownership (insider/major shareholder transactions crossing regulatory thresholds), directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Annual Report (10-K), an Earnings Release (ER), or a general Regulatory Filing (RNS), as it concerns a specific shareholder disclosure requirement.
2020-01-13 French
200113 -Transparantieverklaring persbericht Blackrock .pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring BlackRock, Inc." (Transparency Declaration BlackRock, Inc.) and explicitly mentions a 'Kennisgeving verwijzend naar situatie op 7 januari 2020' (Notification referring to situation on January 7, 2020) and the 'Overschreden drempel: 5%' (Threshold crossed: 5%). It details the acquisition or transfer of voting rights/securities by BlackRock, Inc., which triggers a mandatory disclosure under Belgian law (Article 14 of the law of May 2, 2007). This type of filing, reporting changes in significant share ownership that cross regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it is highly specific to insider/major shareholder transactions.
2020-01-13 Dutch
UCB updates its financial outlook for 2019
Earnings Release Classification · 100% confidence The document is titled "UCB updates its financial outlook for 2019" and provides preliminary, unaudited financial guidance updates (revenue, profitability, EPS) for the full year 2019, while explicitly stating that the full financial statements will be published later on February 20, 2020. This content—a press release announcing key financial highlights and updated guidance before the official, comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K), nor is it a transcript (CT) or a formal presentation (IP). Since it provides the initial announcement of period results/outlook, ER is the most appropriate classification. FY 2019
2020-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.